Name
maxca
Label
Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Units
seconds
Type
numeric
Tags
Visit number vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Follow-up | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Treatment Arm vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 53 | 19.9 | ± 5.1 | 19.2 | 11.6 | 36.2 | 53 | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 60 | 20.3 | ± 5.3 | 19.9 | 11.6 | 38.2 | 46 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 50 | 21.1 | ± 6.8 | 20.6 | 10.2 | 38.0 | 56 | 106 |
Treatment Arm vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 48 | 19.1 | ± 6.8 | 16.2 | 10.9 | 37.8 | 52 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 38 | 19.7 | ± 6.1 | 18.5 | 10.7 | 36.0 | 63 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 37 | 18.9 | ± 5.8 | 18.3 | 10.7 | 34.4 | 63 | 100 |
Age category vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
45-54 years | 23 | 18.9 | ± 5.1 | 17.5 | 11.2 | 27.0 | 30 | 53 |
55-64 years | 61 | 19.2 | ± 5.3 | 18.5 | 10.2 | 34.2 | 78 | 139 |
65 years or older | 79 | 21.7 | ± 6.0 | 21.3 | 11.8 | 38.2 | 47 | 126 |
Age category vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 177 | 300 |
45-54 years | 25 | 16.6 | ± 5.6 | 15.0 | 10.7 | 30.9 | 24 | 49 |
55-64 years | 46 | 18.2 | ± 5.8 | 17.1 | 10.9 | 36.0 | 81 | 127 |
65 years or older | 52 | 21.4 | ± 6.4 | 20.4 | 10.7 | 37.8 | 72 | 124 |
Gender of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 20.4 | ± 5.7 | 19.8 | 10.2 | 38.2 | 155 | 318 |
Female | 42 | 18.4 | ± 5.3 | 17.7 | 10.2 | 38.2 | 42 | 84 |
Male | 121 | 21.1 | ± 5.8 | 20.3 | 11.4 | 38.0 | 113 | 234 |
Gender of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 19.2 | ± 6.3 | 18.0 | 10.7 | 37.8 | 178 | 301 |
Female | 23 | 16.2 | ± 4.0 | 15.0 | 11.6 | 24.3 | 56 | 79 |
Male | 100 | 19.9 | ± 6.5 | 18.5 | 10.7 | 37.8 | 122 | 222 |
Race of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 162 | 20.4 | ± 5.8 | 19.8 | 10.2 | 38.2 | 155 | 317 |
White | 133 | 20.8 | ± 5.7 | 20.1 | 10.2 | 38.0 | 123 | 256 |
American Indian or Alaskan Native | 1 | 17.5 | - | 17.5 | 17.5 | 17.5 | 1 | 2 |
Black or African American | 20 | 20.0 | ± 6.1 | 19.9 | 13.9 | 38.2 | 23 | 43 |
Asian | 2 | 19.1 | ± 7.0 | 19.1 | 14.1 | 24.0 | 4 | 6 |
Native Hawaiian or other Pacific islander | 1 | 17.5 | - | 17.5 | 17.5 | 17.5 | - | 1 |
Other | 2 | 18.5 | ± 2.1 | 18.5 | 17.0 | 19.9 | 2 | 4 |
Multiple | 3 | 11.7 | ± 0.6 | 11.6 | 11.2 | 12.3 | 2 | 5 |
Race of the participant vs Maximum duration of central apneas with no oxygen desaturation threshold used from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 122 | 19.2 | ± 6.3 | 17.8 | 10.7 | 37.8 | 177 | 299 |
White | 102 | 19.6 | ± 6.6 | 18.2 | 10.7 | 37.8 | 139 | 241 |
American Indian or Alaskan Native | 1 | 15.6 | - | 15.6 | 15.6 | 15.6 | 1 | 2 |
Black or African American | 12 | 18.4 | ± 5.0 | 17.8 | 13.0 | 29.6 | 29 | 41 |
Asian | 5 | 16.6 | ± 4.1 | 15.9 | 12.5 | 21.3 | 1 | 6 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | 1 | 1 |
Other | 1 | 15.1 | - | 15.1 | 15.1 | 15.1 | 2 | 3 |
Multiple | 1 | 16.1 | - | 16.1 | 16.1 | 16.1 | 4 | 5 |